Approved Ligands

Aliskiren(CGP 60536) is a direct renin inhibitor with IC50 of 1.5 nM.

Aliskiren(CGP 60536) is a direct renin inhibitor with IC50 of 1.5 nM.

Aliskiren(CGP 60536) is a direct renin inhibitor with IC50 of 1.5 nM.

Aliskiren(CGP 60536) is a direct renin inhibitor with IC50 of 1.5 nM.

Alogliptin is a potent, selective inhibitor of DPP-4 with IC50 of &lt:10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.

Alogliptin is a potent, selective inhibitor of DPP-4 with IC50 of &lt:10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.

Alogliptin is a potent, selective inhibitor of DPP-4 with IC50 of &lt:10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.

Alogliptin is a potent, selective inhibitor of DPP-4 with IC50 of &lt:10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.

Alogliptin is a potent, selective inhibitor of DPP-4 with IC50 of &lt:10 nM, exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9.

Alvimopan is a gastroprokinetic, peripheral-μ-opioid receptor antagonist.A gastroprokinetic, peripheral μ-opioid receptor antagonist.

Alvimopan is a gastroprokinetic, peripheral-μ-opioid receptor antagonist.A gastroprokinetic, peripheral μ-opioid receptor antagonist.

Alvimopan is a gastroprokinetic, peripheral-μ-opioid receptor antagonist.A gastroprokinetic, peripheral μ-opioid receptor antagonist.